Historically, women have been vastly underrepresented in clinical trials — and the issue persists today. This drives health inequities by resulting in treatments that do not fully meet the needs of half the population.
For instance, diseases that predominantly affect women, such as autoimmune diseases, have been slower to receive funding and research attention.
In recent years, a growing number of femtech startups have emerged to address the issues facing women’s health, and these startups are gaining substantial investment as a result.
While women’s health tech funding plummeted from $1.4B to $648M in 2023, several bright spots have emerged within the space. In particular, menopause tech and virtual & hybrid care each saw surges in funding last year.
In the market map below, we identify 199 femtech companies operating across 19 categories.
Please click to enlarge.
Want to see more research? Join a demo of the CB Insights platform.
If you’re already a customer, log in here.
